Europe Wound Closure Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Europe Wound Closure Devices Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Other Products), Wound Type (Chronic Wound and Acute Wound), and End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Other End Users)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Report Code : TIPRE00041360
  • Category : Life Sciences
  • No. of Pages : 170
  • Available Report Formats : pdf-format excel-format
Europe Wound Closure Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Oct 2025   |   Report Code: TIPRE00041360
Buy Now

The Europe wound closure device market size is expected to reach US$ 4,671.45 million by 2031 from US$ 3,227.71 million in 2024. The market is estimated to record a CAGR of 5.6% from 2025-2031.

Executive Summary and Europe Wound Closure Device Market Analysis:

The Europe wound closure devices market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe occupies the second position in the global wound closure devices market and is anticipated to register a significant growth rate over the forecast period. Factors such as the rising prevalence of diabetes and obesity leading to diabetic ulcers and other chronic wounds, rising developmental strategies by market players, and surging technological advancements are aiding market growth.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Europe Wound Closure Devices Market: Strategic Insights

europe-wound-closure-device-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Wound Closure Device Market Segmentation Analysis:

Key segments that contributed to the derivation of the wound closure device market analysis are product, wound type, and end use.

  • By product, the wound closure device market is segmented into sutures, adhesives, staplers, strips, and others. The sutures segment held the largest share of the market in 2024.
  • By wound type, the wound closure device market is bifurcated into chronic wound and acute wound. The chronic wound segment held a larger share of the market in 2024.
  • By end use, the wound closure device market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2024.

Europe Wound Closure Devices Market Report Scope

Report Attribute Details
Market size in 2024 US$ 3,227.71 Million
Market Size by 2031 US$ 4,671.45 Million
CAGR (2025 - 2031) 5.6%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Sutures
  • Staplers
  • Adhesives
  • Strips
  • Others
By Wound Type
  • Chronic Wound
  • Acute Wound
By End Use
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
Regions and Countries Covered Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • B Braun SE
  • Johnson & Johnson
  • Medtronic Plc
  • 3M Co
  • Stryker Corp
  • Baxter International Inc
  • Meril Life Sciences Pvt Ltd
  • CooperSurgical, Inc
  • Smith & Nephew Plc
  • TI Medical
  • Futura Surgicare Pvt Ltd (Dolphin Sutures)
  • Corza Medical GmbH
  • Essity AB
  • Advanced Medical Solutions Group plc
  • Healthium Medtech Limited

Europe Wound Closure Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Wound Closure Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

europe-wound-closure-device-market-cagr

Europe Wound Closure Device Market Outlook

Technological advances are significantly contributing to the wound closure devices market. Advances like bioresorbable sutures, advanced technology tissue adhesives, and improved design surgical staplers offer greater functionality and ease of use for surgeons. These devices reduce complications associated with traditional wound closure methods, such as infection, scarring, and delayed healing. Intelligent sutures that monitor healing and release drugs into the wound are a highly anticipated innovation in the market. Massachusetts Institute of Technology announced in 2023, that it has developed tissue-derived smart sutures, which can not only hold tissue in place but also detect inflammation and release drugs.

Minimally invasive techniques of wound closure are also gaining popularity as they ensure faster recovery, minimal scarring, and fewer complications. For instance, stapling and skin adhesives that result in healing at a faster rate with less damage to tissues are widely used nowadays. In May 2024, Ethicon launched echelon linear cutter, a first-of-its-kind surgical stapler that delivered 47% fewer leaks at the staple line to help reduce surgical risks.

As the healthcare industry places greater emphasis on accuracy and patient-centered therapy, applications for these next-generation wound closure technologies will increase over the next several years, setting technological innovation among the strongest influences in driving growth in the industry. Smart materials and enhanced biocompatibility are also factors contributing to the market, enabling devices for wound closure to become both more efficient as well as more patient friendly.

Europe Wound Closure Device Market Country Insights

Based on country, the Europe wound closure device market comprises Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany held the largest share in 2024.

The presence of various manufacturers and wound management societies helps create awareness about the efficient use of wound care products. For instance, the German Wound Healing Society introduced guidelines to prevent and treat wounds. It is working to educate professionals on the latest wound healing techniques and offers certified diploma courses for wound healing. It provides reimbursement contracts for wound treatments with health insurance and supports funding for scientific work to active members of the German Association of the Scientific Medical Societies. Further, key players in Germany are expanding their product lines to increase market presence. In June 2021, Bactiguard and Schulke signed an exclusive distribution agreement for Bactiguard's range of wound care solutions to German hospitals. The collaboration enables Schulke to complement its range of antiseptic and wound care products with Bactiguard's hypochlorous acid-based portfolio.

Company Profiles

Some of the key players operating in the market include Healthium Medtech Limited, Advanced Medical Solutions Group plc, Essity AB, Corza Medical GmbH, Futura Surgicare Pvt Ltd (Dolphin Sutures), TI Medical, Smith & Nephew Plc, CooperSurgical, Inc, Meril Life Sciences Pvt Ltd, Baxter International Inc, Stryker Corp, 3M Co, Medtronic Plc, Johnson & Johnson, and B Braun SE, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Wound Closure Device Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations.
  • Industry trade journals and other relevant publications.
  • Government documents, statistical databases, and market reports.
  • News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research.
  • Enhance the expertise and market understanding of the analysis team.
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

in the market.

Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA
Page Updated: Dec 2025